KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $250.4 million.

  • Resmed's Accounts Payables rose 1365.92% to $250.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $250.4 million, marking a year-over-year increase of 1365.92%. This contributed to the annual value of $278.2 million for FY2025, which is 1700.64% up from last year.
  • As of Q4 2025, Resmed's Accounts Payables stood at $250.4 million, which was up 1365.92% from $266.8 million recorded in Q3 2025.
  • Resmed's Accounts Payables' 5-year high stood at $278.2 million during Q2 2025, with a 5-year trough of $117.2 million in Q1 2021.
  • In the last 5 years, Resmed's Accounts Payables had a median value of $179.5 million in 2022 and averaged $193.7 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first tumbled by 533.08% in 2023, then skyrocketed by 5769.06% in 2024.
  • Quarter analysis of 5 years shows Resmed's Accounts Payables stood at $163.4 million in 2021, then increased by 19.98% to $196.0 million in 2022, then rose by 3.26% to $202.4 million in 2023, then rose by 8.85% to $220.3 million in 2024, then increased by 13.66% to $250.4 million in 2025.
  • Its last three reported values are $250.4 million in Q4 2025, $266.8 million for Q3 2025, and $278.2 million during Q2 2025.